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Abstract 
Fluoroquinolones are an essential class of antibacterial, and widely used in clinical 
application. This thesis concerns the spectroscopic and theoretical investigation of four 
fluoroquinolones (Ofloxacin, Ciprofloxacin, Norfloxacin and Enoxacin) derivatives. The 
experiment results were performed with IR spectroscopy, UV- visible spectroscopy and 
emission spectroscopy. Theoretical calculations were performed with Gaussian03 and 
HyperChem software Packages. The observed IR spectra were recorded in KBr and 
corresponding theoretical calculations were performed with Density Functional Theory, using 
the B3LYP functional and the 6-31G* basis set (B3LYP/6-31G*). The observed UV- Vis 
spectra were recorded in pure methanol solvent and relevant theoretical calculations were 
performed with density functional theory (DFT) by using the B3LYP functional and the 6-
31G* basis set (B3LYP/6-31G*). The emission spectra of drugs were recorded in pure 
ethanol solvent. The fluorescence quantum yield of two standard samples (anthracene & 9, 10 
- diphenyl anthracene) were calculated by Jobin Yvon Horiba method. The vertical excitation 
energies, electron affinities and ionization potential were calculated in solvent (water) by  
B3LYP/6-31+G(d,p)//6-31G(d) scrf(pcm,solv=water)  and in vacuum by B3LYP/6-
31+G(d,p)//6-31G(d) [(vacuum)] method. 
The observed IR spectra have given good agreement with corresponding theoretical 
predictions.  The λmax of the drugs located at 300 nm and 296 nm of ofloxacin, at 276 nm and 
267 nm of enoxacin, at 283 nm and 280 nm of norfloxacin and at 283 nm and 282 of 
ciprofloxacin in both the observed spectra and theoretical predictions. The observed spectra 
show good agreement with theoretical predictions. Ciprofloxacin fluoresces with an emission 
spectrum is located at λmax = 429 nm. Different emission peaks are observed in other three 
dugs samples. The calculated fluorescence quantum yield of two standard samples is found 
similar to the literature values. Theoretical calculations of IE & EA in water are calculated 
different in vacuum by Gaussian03. 
 
Keywords: Ofloxacin, Ciprofloxacin, Norfloxacin, Enoxacin, theoretical calculations, IE, 
EA, IR, UV –Visible and emission spectroscopy. 
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Glossary 
DFT Density Functional Theory 
IR  Infrared Spectroscopy 
 
Photoallergy An acquired, immunologically mediated 
reaction to a drug or chemical initiated by the 
formation of photoproducts when that drug or 
chemical is exposed to light. 
 
Photoirritation or Photochemical 
irritation 
A light-induced, nonimmunologic, skin 
response to a photoreactive drug or chemical. 
Photoproducts Compounds resulting from absorption of 
radiation by a drug or chemical 
 
Photoreactive Drugs or chemicals that react with another 
molecule in the formulation or skin after 
exposure to UVA, UVB, or visible radiation 
 
Photosensitivity A photoirritation or  photoallergy-induced 
reaction 
 
Photosensitizer A drug or chemical that causes an adverse 
effect in the presence of UVA/UVB 
or visible light 
 
Pseudomonas species A genus of gram-negative, motile, non-spore-
forming, rod-shaped bacteria that cause a 
variety of infectious diseases in animals and 
humans  and in plants 
UV Ultraviolet radiation (wavelengths between 
10 and 400 nm) 
UVA Ultraviolet radiation A (wavelengths between 
iv 
 
320 and 400 nm) 
 
UVB Ultraviolet radiation B (wavelengths between 
290 and 320 nm) 
 
UVC Ultraviolet radiation C (wavelengths between 
200 and 290 nm) 
 
VIP Vertical Ionization Potential 
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Chapter 1 
1.1. Introduction 
This thesis concerns the spectroscopic and theoretical investigation of four fluoroquinolones 
(Ofloxacin, Ciprofloxacin, Norfloxacin and Enoxacin) derivatives. This project was 
originally suggested by Leo Pharma with the aim of investigating the possible origin of the 
relative phototoxicities of these compounds, which are applied as drugs in the treatment of 
skin diseases like psoriasis etc. In the start, the idea was to study the fluorescence spectra and 
quantum yields for these fluoroquinolones. But due to weakness of fluorescence and 
apparently small quantum yields, combined with lack of professional skills and shortage of 
time, this study was not successful (initial results for two standards were acceptable, see 
3.6.3). Therefore the experimental part of this project is limited to optical IR and UV-VIS 
absorption spectroscopy. Theoretical calculations were performed to compare with the 
experimental results, and possibly throw some light on the factors affecting the relative 
phototoxicities. Theoretical semi-empirical calculations were performed by using 
HyperChem and Gaussian software packages. The theoretical calculations were performed in 
Gaussian and corresponding calculations were repeated in HyperChem.  
1.2. Fluoroquinolones 
Fluoroquinolones are an essential class of antibacterial, and widely used in clinical 
application (Andriole, 1999). In 1986, fluoroquinolones were introduced and they were 
modified from the class of antibiotics known as quinolones in early 1960. Quinolones consist 
of bicyclic ring structure and different functional groups are substituted at position N-1 as 
shown in figure 1.1. 
 
Figure 1.1: Structure of Fluoroquinolones 
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Carboxyl group is substituted at 3 positions, a keto group at 4 positions, fluorine atom at 6 
positions and piperazinyl group or a methyl piperazinyl group at C-7 position. Presences of 
different functional group at N-1 or at C-7 positions influence both microbiological and 
pharmacokinetic properties (Von Rosenstiel et al, 1994). 
In the start, fluoroquinolones were administrated orally for the treatment of infection caused 
by gram-negative organisms and Pseudomonas species. Now-a-days fluoroquinolones have 
wider clinical application against gram-positive and gram-negative aerobic and anaerobic 
organisms. Several fluoroquinolones play a vital role for the treatment of community-
acquired pneumonia and intra-abdominal infections.  
In this project, the following four fluoroquinolones derivatives have been used for the optical 
spectroscopic and theoretical investigations.   
1.2.1. Ofloxacin 
It is belong to the group of antibiotic and is widely used  to treat bacterial infections that 
causes bronchitis, pneumonia, chlamydia, gonorrhea, skin infections, urinary tract infections, 
and infections of the prostate [Belal et al, 1990] . 
 
 
 
Figure 1.2: Structure of Ofloxacin 
1.2.2. Enoxacin 
It is an antibiotic and used for the treatment of infections caused by bacteria, such as sexually 
transmitted diseases. For example gonorrhoea and urinary tract infections including cystitis. 
It does not work for other viral infections like cold, flu etc. 
[http://www.nlm.nih.gov/medlineplus/druginfo/medmaster]  
 
Figure 1.3: Structure of Enoxacin 
O
NN
N
O
F
O
O
N
N
NN
O
F
O
O
 3 
 
1.2.3. Norfloxacin 
It is belong to second generation quinolones and significantly increase antibacterial activity 
than the previous quinolones. It was the first quinolone antibiotic that has substituted fluorine 
atom at position C-6 and a piperazine at the C-7 .It is used against both Gram-positive and 
Gram-negative organisms [Belal et al, 1990]. 
 
 
 
 
 
 
 
Figure 1.4: Structure of Norfloxacin 
1.2.4. Ciprofloxacin: 
(1-cyclopropyl-6-fluoro-1, 4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolone carboxylic acid) 
Ciprofloxacin is a broad spectrum antibiotic and belong to second generation quinolone. It 
shows low toxicity and greater potency. It is administrated orally and parenterally. 
Ciprofloxacin is distributed widely and absorbed very well in different body tissues and 
fluids. It is widely used in various types of infections of urinary track, respiratory track and 
gastrointestinal track and also for skin and soft tissues infections. Ciprofloxacin has been 
recommended by the Food and Drug Administration (FDA) for prophylaxis of inhaled 
Bacillus anthracis infection [Nora et al, 1990].  
 
 
 
 
 
Figure 1.5: Structure of Ciprofloxacin 
The above four fluoroquinolones derivatives have been selected in this project because they 
are widely used for different kind of bacterial infections. 
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Chapter 2 
2.1. Infrared Spectroscopy 
Infrared spectroscopy (IR) is mostly used by organic and inorganic chemists. In very simple 
way, it is the absorption measurement of IR frequencies of the sample positioned in the path 
of IR beam. Organic and inorganic molecules absorbed IR radiations and converted it into 
vibrational, stretching and bending molecular energy. Different functional groups and bonds 
absorbed infrared radiation at various wavelengths. 
Electromagnetic radiations lower in energy than visible radiations are called infrared 
radiations. The electromagnetic spectrum of infrared region is divided into three parts, the 
near - , the mid - , and far – infrared region. The near - infrared  region  lies between  14000 -
4000 cm-1  , mid region between 4000 - 200 cm-1  and far region 200 - 10 cm-1.When the 
electromagnetic radiations of Infrared region is fall on the molecule, it absorbed the energy 
and the amount of absorbed energy is enough for the vibration motion of molecule. The 
energy which is not absorbed is transmitted through the sample. A graph plotted between 
absorbance and wave number is known as infrared spectrum. 
A bond in an organic molecule may either stretch or bend with respect to other bonds. In 
stretching vibration, the inter - nuclear distances between two atoms increases or decreases 
but the atoms remain at the same bond axis.e.g. 
 The figure 2.1 shows a change in bond length (inter-atomic distance) along bond axis is an 
example of stretching vibration. The variation in stretching vibration is symmetrical and 
asymmetrical [Pavia et al, 1997]. 
 
Bond stretch Normal bond length Bond compressed
 
Figure 2.1: Stretching vibration. 
 In the bending vibration, the position of the bond changes with respect to original bond axis. 
e.g.  
The figure 2.2 shows the bending vibration produces a change in angle between two bonds.  
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Bond angle
compressed
Normal 
bond angle
Bond angle
widened
 
Figure 2.2: Bending vibration 
. 
The variations in bending vibrations are in the plane of the molecule or out of plane 
scissoring like blades of a pair of scissors, or rocking, where two atoms move in the same 
direction. 
H
 
H
 
In plane Out of plane 
Figure 2.3:  Variation in bending vibrations in the plane or out of the plane. 
For stretching and bending vibration in a molecule, a definite amount of energy is required. 
This quantum of energy is provided by infrared part of electromagnetic radiations. Out of the 
many possible stretching and bending vibrations only those vibrations are capable of 
absorbing infrared radiations which cause a change in dipole moment. These kinds of 
vibrations are called IR active vibrations and appear in the IR spectrum. The peak intensity is 
proportional to the amount of change in dipole moment [Pavia et al, 1997]. 
2.2. IR Spectra 
The IR Spectra of the four drugs were recorded by using Perkin – Elmer 2000 FT-IR 
instrument. All the spectra were recorded at room temperature. The observed spectrum is 
very complicated. The present information is not enough for the assignment of the broad, 
intense features in the spectra. It is a challenge and cannot be made just by reference to group 
frequency tables and the results of calculations on isolated molecules. The more information 
is required about the packing of molecules in crystal lattice; information on the 
intermolecular interactions in the crystal (dimer formation) 
The theoretical calculations were performed with the Gaussian03 software package. The 
calculations were performed with Density Functional Theory, using the B3LYP functional 
and the 6-31G* basis set (B3LYP/6-31G*). The wavenumbers have been scaled by  
a constant factor, alpha = 0.9614, to correct for systematic errors in the theoretical model. 
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The curves shown in the graphs were constructed under the assumption of Lorentz lineshape 
with "half-width at half maximum" (HWHM) = 7 cm-1. 
 
2.2.1. Sample Preparation 
The potassium bromide is well salt for the measurement of mid IR because it does not have 
any absorption in this region. Therefore the sample tablets were prepared in KBr. The tablets 
were prepared by using 200 mg of pure dry KBr powder and almost 2 mg of the drug 
samples.  
2.2.2. Ofloxacin 
In the experimental spectrum the compound was in solid crystalline state and in theoretical 
spectrum the molecule was isolated in the gas phase. The experimental and theoretical spectra 
of ofloxacin are shown in figure 2.4. In the previous study (Sagdinc et al, 2003), the same 
experimental spectrum was obtained. 
In the experimental spectrum (figure 2.4) the broad peak from 3300 to 3700 cm-1 assigned to 
water .The correspondence peak is not seen in the theoretical spectrum (figure 2.4). It may be 
due to that the experimental sample contains moisture in KBr. The band region from 3000 to 
3100 cm-1 is assigned to carboxylic acid O-H stretch in both spectra. The difference in 
intensities is seen may be due the intra molecular H-bonding between the carboxyl hydroxy 
group and the keton carbonyl group in experimental spectrum. The bond region from 1400 to 
1800 is comparable in both spectra. The band region from 1650 to 1800 cm-1 is assigned to 
carboxylic acid C=O stretch and 1500 to 1650 cm-1 keto C=O stretch in both spectra. 
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Figure 2.4: IR observed and theoretical predicted spectra of ofloxacin. 
2.1.3. Enoxacin 
The experimental and theoretical spectra of enoxacin are shown in figure 2.5. The compound 
in the experimental spectra was in solid crystalline state and the calculation was performed in 
gas phase. 
. 
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Figure 2.5: IR observed and theoretical predicted spectra of enoxacin. 
The stretching vibration of an isolated, uncomplexed N-H group gives rise to a weak  
transition that cannot easily explain the huge intensity of the observed band with  
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maximum around 3400 cm-1. The O- H stretch of carboxylic acid in both spectra appears 
between 3000 – 3200 cm-1.The difference in the peak intensities in both spectra may occur 
because of intra molecular hydrogen bonding between the carboxyl hydroxy group and the 
keton carbonyl group in experimental spectrum. The C=O stretch of carboxylic acid is seen 
between 1600 to 1700 cm-1 in the experimental spectrum and 1700 to 1800 cm-1 in the 
calculated spectrum. The band region from 1500 to 1700 cm-1 assigned to C=O stretch of 
keton in both spectra. 
2.1.4. Norfloxacin 
The experimental and theoretical spectra of norfloxacin are shown in figure 2.6. The 
compound in the experimental spectra was in solid crystalline state and the calculation was 
performed in gas phase. 
The stretching vibration of an isolated, uncomplexed N-H group gives rise to a weak  
transition that cannot easily explain the huge intensity of the observed band with  
maximum around 3400 cm-1. The carboxylic acid O- H stretch in both spectra appears 
between 3000 – 3200 cm-1.The difference in the peak intensities in both spectra may occur 
because of intra – molecular hydrogen bonding between the carboxyl hydroxy group and the 
keton carbonyl group in experimental spectrum. The carboxylic acid C=O stretch peak is 
seen between 1600 to 1800 cm-1 in both spectra. The band region from 1500 to 1700 cm-1 
assigned to C=O stretch of keton in both spectra.  
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Figure 2.6: IR observed and theoretical predicted spectra of norfloxacin. 
2.1.5. Ciprofloxacin 
The experimental and theoretical spectra of ciprofloxacin are shown in figure 2.7. The 
compound in the experimental spectra was in solid crystalline state and the calculation was 
performed in gas phase. 
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Figure 2.7: IR observed and theoretical predicted spectra of ciprofloxacin 
The stretching vibration of an isolated, uncomplexed N-H group gives rise to a weak  
transition that cannot easily explain the huge intensity of the observed band with  
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maximum around 3400 cm-1. The carboxylic acid O- H stretch in both spectra appears 
between 3000 - 3200 cm-1. The difference in peak intensities of the both spectra may occur 
because of intra - molecular hydrogen bonding between the carboxyl hydroxy group and the 
keton carbonyl group in experimental spectrum. The carboxylic acid C=O stretch peak is 
seen between 1600 to 1800 cm-1 in both spectra. The band region from 1500 to 1700 cm-1 
assigned to C=O stretch of keton in both spectra.  
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Chapter 3 
 3.1. UV-Vis Absorption Spectroscopy: 
Ultraviolet and visible (UV-Vis) absorption spectroscopy is the measurement of light when it 
is passed through a sample. The principle of UV-Vis spectroscopy is based on the ability of 
molecule to absorb ultraviolet and visible light. The absorption of light corresponds to the 
excitation of outer electrons in the molecule. When a molecule absorbs energy and the outer 
electrons in the molecule excited from the Highest Occupied Molecular Orbital (HOMO) to 
Lowest Unoccupied Molecule Orbital (LUMO).The occupied molecular orbitals with lowest 
energy are known the σ orbitals, at slightly higher energy are called π orbitals and at still 
higher energy are known non – bonding orbitals (unshared pair electrons). The π* and  σ* are 
called the highest energy state. The figure 3.1 shows the electronic energy levels and 
transitions [Pavia et al, 1997]. 
 
Figure 3.1: Electronic energy level and transition state [Pavia et al, 1997 ] 
The absorption can be measured at a single wavelength or on spectral extended range. 
Ultraviolet and visible spectroscopy are enough energetic to excite outer electrons to high 
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energy level and it is very useful for quantity measurement. The Beer – Lambert Law is used 
to determine the concentration of analyte by measuring the absorbance at various 
wavelengths. Beer – Lambert Law is the relationship between absorbance and concentration. 
It can be written as. 
1.3...........................................clA ε=  
Where ‘A’ is the absorbance, ‘ε’ is the molar absorbtivity and expressed in units L mol-1 cm-1, 
‘c’ is the concentration of the sample (compound) and expressed as mol L-1 and ‘l’ is length 
of cell and expressed in units cm [Pavia et al, 1997]. 
3.2. UV -Vis Spectra 
Absorption spectra of the four drug samples were recorded by using UV-Vis 
spectrophotometer (Mode UV -2101 PC Shimadzu).The light generated from a Xenon flash 
lamp and is passed through the monochromator which splits the beam into different 
wavelengths out of the continuous spectrum.  The intensity ‘I0’ measured by the fraction of 
beam redirected using beam splitter. The transmitted intensity ‘I’ of the light beam is 
measured at photodetector and the absorbance is calculated by the following formula. 
 
2.3...........................................log 0
I
IA =
 
The absorption is plotted as a function of the wavelength in an absorption spectrum. The 
molar absorptivity is calculated by using the Beer – Lambert law (Equation 3.2). The 
concentration of each sample is shown in table 3.1 and the length of cell is 1cm. 
The theoretical calculations were performed with the Gaussian03 software package. The 
geometries were optimized with density functional theory (DFT) by using the  
B3LYP functional and the 6-31G* basis set (B3LYP/6-31G*). The electronic transitions 
were computed with Time Dependent Density Functional Theory (TD-DFT), but using a 
larger basis set: TD-B3LYP/6-31+G*. The "+" indicates diffuse functions in the basis set. 
 3.2.1. Sample Preparation 
The drug samples (Ofloxacin: C18H2OFN3O4, Norfloxacin: C16H18FN3O3, Enoxacin: 
C15H17FN4O3 and Ciprofloxacin: C17H18FN3O3) were kindly provided by research scientist 
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Kim T. Nielsen, LEO Pharma A/S, Industriparken 55 ·  DK-2750 Ballerup Denmark. These 
drugs samples were purchased from Sigma – Aldrich. The solvent methanol of uvasol 
standard (99.9% pure) was purchased from Merck KGaA, Frankfurter Str. 250 64293 
Darmstadt Germany. 
The solutions of fours drugs samples were prepared in pure methanol (solvent).The 
concentration of each drug sample is shown in table 3.1. 
Sample (Drugs) Concentration (mole/l) 
                         Ofloxacin 3.87*10-5 
                         Enoxacin 7.49*10-5 
                         Norfloxacin  3.76*10-5 
                         Ciprofloxacin   3.62* 10-5 
Table 3.1: Concentration of drug sample 
3.2.2.  Ofloxacin 
The observed and theoretical spectra of ofloxacin in an organic solvent (methanol) are shown 
in figure 3.2.The λmax in observed spectrum is located at 300 nm with shoulders at 228 nm, 
257 nm and 329 nm. In the previous study, almost similar spectrum of ofloxacin was 
observed in the methanol [Park et al, 1999].The λmax in the theoretical spectrum is found at 
296 nm with shoulders at 228 nm and 347.The above discussion shows the good agreement 
between observed and theoretical predications. 
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Figure 3.2: Observed and theoratical spectra of ofloxacin 
3.2.3. Enoxacin 
The observed UV –Vis spectrum of enoxacin in organic solvent (methanol) is shown at the 
top in figure 3.3. The results from 6-31G* basis set (B3LYP/6-31G*) – PCM methanol 
calculations are shown at the bottom of figure 3.3. In the observed spectrum, λmax is located at 
276 nm with two shoulders at 221 nm and 345nm.In the correspondence theoretical spectrum, 
λmax is located at 267 nm with two shoulders at 217 nm and 330 nm. Thus, the above 
discussion shows very good agreement between observed and theoretical predictions. 
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Figure 3.3: Observed and theoratical spectra of enoxacin 
3.2.4. Norfloxacin 
The observed and theoretical predictions of norfloxacin are shown in figure 3.4. The 
observed spectrum was recorded in an organic solvent methanol and theoretical calculations 
performed in 6-31G* basis set (B3LYP/6-31G*) – PCM methanol. In the observed spectrum, 
λmax is located at 283 nm with shoulders at 226 nm, 317 nm and. The λmax in theoretical 
spectrum is located at 280 nm with shoulders at 233 nm and 327 nm.Thus, this discussion 
shows the good agreement between experimental spectrum of norfloxacin in methanol and 
theoretical predictions using 6-31G* basis set (B3LYP/6-31G*) – PCM methanol. 
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Figure 3.4: Observed and theoratical spectra of norfloxacin 
3.2.5. Ciprofloxcin 
The observed spectrum of ofloxacin in an organic solvent (methanol) and theoretical 
predictions using 6-31G* basis set (B3LYP/6-31G*) – PCM methanol are shown in figure 
3.5.The λmax in observed spectrum is located at 283 nm with shoulders at 222 nm and 320 
nm.Thus λmax in the theoretical spectrum is found at 282 nm with shoulders at 239 nm and 
332.The above discussion shows the good agreement between observed and theoretical 
predications. 
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Figure 3.5: Observed and theoratical spectra of ciprofloxacin 
3.3. Emission Spectroscopy 
When a molecule absorbs a light in the UV-Visible region, it goes to excited and rapidly after 
the emission of light photons, it returns to the ground state. This whole process is known as 
fluorescence. The energy absorbed by chemical compounds causes the excitation of electrons 
in the molecule. For the occurrence of transition, the energy absorbed by the molecule must 
be equal to the difference between the initial electronic state and high energy state. This 
constant value characterizes the molecular structure and termed as excitation wavelength. If it 
allow the excited molecule to return at the ground state by the emission of energy through 
heat or photons. This emission of energy is also equal to the difference between the two 
discrete energy states. This emission energy is the characteristics of molecular structure. 
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Simply, when a molecule absorbs energy in the UV region (200 - 900), it goes to higher 
energy state and return to initial state in less than 10-9 sec after the emission of energy 
calculated [Chien et al, 1995; Guilbaultm, 1995].  
3.4. Emission Spectra 
UV –Vis absorbance spectra of all the four drugs were recorded by using UV- Vis 
spectrophotometer (Mode UV -2101 PC Shimadzu) .Write down the absorbance of each 
sample at excitation wavelength 320 nm. 
The fluorescence spectra were recorded on “Fluorolog Jobin Yvon Horiba” instrument with a 
slit of 10 nm and at excitation wavelength 320 nm by Jobin Yvon Horiba method. The 
emission spectra of ofloxacin, enoxacin and norfloxacin are shown in appendix A 1, A 2 & A 
3.  
3.4.1. Sample Preparation 
The samples of all the four drugs were prepared in pure ethanol. In order to minimize the re-
absorption effects, the sample solutions were prepared of such concentrations those should 
not have absorbance higher than 0.1 at and above the excitation wavelength. The 
concentration of each sample at excitation wavelength 320 nm is shown in table 3.2.   
Sample (Drugs) Concentration (mole/l) 
                         Ofloxacin 2.83 *10-6 
                         Enoxacin 3.71*10-6 
                         Norfloxacin  2.77*10-5 
                         Ciprofloxacin   4.21*10-6 
Table 3.2: Concentration of drugs 
 
3.4.2. Ciprofloxacin 
The UV – Vis absorption spectrum and the emission spectrum of ciprofloxacin in ethanol are 
shown in figure 3.6 .The λmax in the UV - Vis absorption spectrum is located at 283 nm with 
shoulder at 320 nm. As seen in figure 3.6, ciprofloxacin fluoresces with an emission spectrum 
is located at λmax = 429 nm.The emission spectra of other three dugs shows more than one 
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peaks (Appendix A 1, A 2 & A 3). These peaks may be due to some impurities and artifact of 
lamp profile.   
 
 
Figure 3.6: UV-Vis & Emission spectra of Ciprofloxacin 
3.5. Fluorescence Quantum Yield 
When a photon of light is absorbed by fluorophore and it goes to excited state. At the end, it 
returns to ground state after the loss of energy. The fluorescence quantum yield (ΦF) is the  
number of photons emitted, divided by the number of photons absorbed. In other way, the 
probability of the excited state being deactivated through fluorescence. The comparative 
method of William et al [William et al,] is suitable for measure the quantum yield because it 
use well characterized  standard samples with given quantum yield. The solutions of standard 
and test samples with same absorbance at identical excitation wavelength are supposed to 
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absorb the same number of photons. Therefore, a ratio of integrated fluorescence intensities 
of the two solutions gives the ratio of quantum yield value of the two solutions. Thus, in this 
way ΦF of standard is known and the quantum yield of test sample is calculated [Chien et al, 
1995; Guilbaultm, 1995]. 
3.6. Emission Spectra 
UV –Vis absorbance spectrums of all the above solutions were recorded by using UV- Vis 
spectrophotometer (Mode UV -2101 PC Shimadzu) .Write down the absorbance of each 
sample at excitation wavelength (320 nm).Recorded the fluorescence spectrum of all the 
above solutions on “Fluorolog Jobin Yvon Horiba” instrument with a slit of 10 nm by Jobin 
Yvon Horiba method. The excitation wavelength for all the samples was 320 nm. All data 
were saved in ASCII format. The graphs of integrated fluorescence intensity against 
absorbance were plotted for all samples and the expected result should be the same straight 
line with slope m and intercept 0. Graphs were plotted in “Origin Pro Lab Software”. 
3.6.1. Standard Sample Preparation:  
The solvents ethanol of uvasol standard (99.9% pure) was purchased from Merck KGaA, 
Frankfurter Str. 250 64293 Darmstadt Germany. The standard samples anthracene (99% 
pure) and 9, 10 – Diphenylanthracen (99% pure) for emission spectroscopy were purchased 
from Lancaster Synthesis Ltd. (Europe) Eastgate, Whiste Lund, Morecambe Lancashire, LA3 
3DY Great Britain.Two standards anthracene and 9, 10 – diphenyl anthracene samples are 
selected and prepare the following five solutions of both samples in ethanol (solvent). 
Anthracene 9,10 – Diphenyl anthracene 
Concentration 
(mole/l) 
UV –Vis  absorption at 
wavelength 320 nm 
Concentration 
(mole/l) 
UV –Vis  absorption at 
wavelength 320 nm 
3.57 * 10-5 0.11 7.69 * 10-5 0.11 
2.45 * 10-5 0.07 4.81 * 10-5 0.09 
1.62 *10-5 0.05 3.26 * 10-5 0.07 
8.44 * 10-6 0.019 1.67 * 10-5 0.04 
6.49 * 10-7 0.015 1.28 * 10-5 0.027 
Table 3.3: Concentrations of standard samples  
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3.6.3 Calculation of Quantum Yield 
The quantum yields of two standards were calculated by plotting absorbance against 
integrated fluorescence intensities as shown in figure 3.7.Then calculated the gradient of both 
lines and quantum yield was calculated by the following equation. 
3.3..........................................................)(
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2
2
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The subscripts ‘X’ and ‘ST’ denote sample and standard, ‘Grad’ is the gradient calculated 
from the plots of sample and standard (Figure 3.7), φ is the fluorescence quantum yield and η 
is the refractive index of solvent.   
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Figure 3.7: The straight line of the two samples.  
 25 
 
40.090.0/36.0:
32.01/32.0:
00.1*)(
)(
1.00 - 0.90  Cyclhex)(st, 
 0.36 - 0.32  Cyclhex)(X, 
 valuesliterature  theUsing
03.046.000.1*)(
)(
0.4945  2.67E9) E11E9)/(1.021 2.15  E10 4.702 ( : Maximum
0.4283  2.67E9)- E11E9)/(1.021 2.15 - E10 4.702 ( : Minimum
rad)st(Grad)x/(G  of Ratio
2.67E9  1.021E11  (st) Grad
E9 2.15 E10 4.702  (X) Grad
gradients Observed
)(
)(
HoribaYvon Jobin    Using
ethanolin   thraceneDiphenylan - 9,10 st 
ethanolin  Anthracene
2
2
=
=






=
=
=
±=





=
=++
=
±=
±=














=
=
=
Maximum
Minimum
Grad
Grad
Grad
Grad
Grad
Grad
X
ST
X
ST
X
ST
X
ST
X
ST
X
ST
X
STX
φ
φ
φ
φ
φ
φ
η
ηφφ
 26 
 
Chapter 4 
4.1. Phototoxicity 
The molecules that absorb the photon of UV radiation or visible light may lead to phototoxic 
effects [Castell, 1998]. According to Grottus’ law (First law of photochemistry), molecule 
must absorb light to start the photochemical reaction which leads to excited state. Some 
molecules from excited state may emit energy in the form of fluorescence (emission of light).  
Photophysical and photochemical studies of exogenous (external) photoactive molecules lead 
to the excited states study and guide to the mode of action of excitation energy in vivo 
(Figure 4.1) [Lakowicz et al, 2001]. 
 
Figure 4.1: The photo excitation of endogenous and exogenous chromospheres can lead to 
either re-emission of light or the absorbed radiation partially converts into thermal or 
chemical energy [Karu et al, 1999].  
   
The “photodynamic diagnosis” (PDD) also known as “photodiagnosis” (PD) is extensively 
used for the clinic detection of skin cancer  [Banerjee et al, 2000].The excitation energy of 
photoactive molecule re - emits as fluorescence. The excited photoactive molecule in the 
presence of internal conversion leads to the local heating of the tissue during photothermal 
therapy [Jori et al, 1990]. The excitation of photoactive molecule may lead to different 
photoreactions like indirect photodynamic action and direct photo activation of 
pharmaceutical. These effects in later known as photodynamic effect and used in 
photodynamic therapy (PDT) [Schance, 1997]. The photophyical processes in PD, PDT and 
PTT (Photothermal therapy) are discussed in detail (figure 4.2). 
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Figure 4.2: Photophysical and chemical processes involve in PDT (7 - 9), PTT (3, 6) and PD 
(2, 5) [Szaciłowski et al, 2004] 
The S0 is the electronic singlet state of ground state photosensitizer. With the absorption of 
light, the photosensitizer goes to first excited state (S1) (1) for a short time.  The 
photosensitizer can go back to ground state by the emission of absorbed energy (2) or internal 
conversion (3).In the other hand S1 can go to the first excited triplet state (T1) with high 
quantum yield by intersystem crossing (4). The photosensitizer from the first excited triplet 
state (T1) can returns to ground state either by emitting phosphorescence (5) (release energy) 
or nonradioactive path (6).The long lived photosensitizer at first excited triplet state (T1)  can 
involve in chemical reactions by transferring of electron or hydrogen to make a radical 
intermediate, which take a part in photodynamic reactions of type I (8).Photosensitizer from 
the triplet state transfer energy (9) to the acceptor (Oxygen), that leads to creation of highly 
reactive singlet oxygen , which take a part in photodynamic reaction type II (10).Singlet 
oxygen and radical intermediates( (ROS) oxygen is a main reactive species) are cytotoxic 
agents and in PDT, type II mechanism is dominant for many cases. At low oxygen and high 
substrate concentration, type I reactions are more favorable.  
Many organic and inorganic drugs are able to go through photochemical reactions in vivo and 
ex vivo. Vivo photochemical reactions may lead to photoallergies and many undesired 
phototoxic effects. Ex vivo photochemical reactions induced the degree of physiological 
reactivity or creation of harmful and phototoxic product. A drug considered to be phototoxic, 
when light causing biological deleterious effect from photoirratation to photocarcinogenicity. 
Photoirritation is non immunological response of photoreactive chemicals directly to the skin 
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or via circulatory system following systemic administration. Photoallergy is an 
immunological response of photoproducts with proteins, nucleic acid and itself. 
Photogenotoxicity is a genotoxic response of photoactivated chemicals by UV or visible 
light. Photophysicists and photochemists used the term “photosensitiser” to illustrate the 
compounds that absorb the light and provoke the chemical changes in other molecules. When 
“photosensitiser” come in contact with biological system, leads to short term (acute) or long 
term (chronic) phototoxic effects. These phototoxic effects can be monitor as cytotoxicity, 
inflammation and cell death. The compounds that damage the DNA initiating process are 
called genotoxic photosensitiser. The genotoxic photosensitiser enhances such a process that 
leads to phototumorogenesis. It has been noted that these biological effects are dose 
dependent. In clinical application of drugs, phototoxic effects are observed when light 
absorbing chemicals are applied to the body exposed by sunlight. For this reason academic 
researcher and cosmetic industries have been engaged in the improvement of in vitro models 
and their validations [Jose et al, 1999]. In 1993, the European Center for Validation of 
Alternative Methods organized a workshop to deal with the phototoxic issue [Spielmann et al, 
1994].  
4.2. Case Study of Napthazarin 
In this project for the theoretical study of photochemical properties of the four drugs, the 
following approach has been used as an example. 
The photosensitizing mechanism of naphthazarin and the halogen substitutes (NAS) was 
investigated by TD – DFT method. The NAS photosensitization consists of two type 
mechanism. In type I mechanism NAS react directly with substrate (DNA, RNA and 
proteins) and type 2 mechanisms involve the generation of toxic ROS (Singlet oxygen and 
radical intermediate) by the transfer of electron and energy. In 2006, Kang et al found that 
NA and its derivative upon excitation affect the DNA. In oxygen free media, two types of 
route involved for the photo damage by Type1 mechanism. In first step, NAS can take an 
electron from DNA at first transition state T1 (equation1).In the second step autoionization of  
NAS take place between  S0 and T1 states (equation 2) or  both at T1(Equation 3) and form 
cation radical (NAS.+). After the generation of (NAS. +), it may accept electron from DNA 
(Equation 4.4). 
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Reaction 4.1 is based on vertical electron affinity at T1 (VEAT) of NAS and vertical 
ionization potential (VIP) of D (DNA or RNA). The reaction is only favorable when the sum 
of these two factors (VEAT & VIP) is negative. The sum of VEAT of NAS and VIP of DNA or 
RNA bases was calculated positive in water and ether. Therefore the electrons transfer 
between T1 state of NAS and DNA or RNA bases are not thermodynamically permitted. The 
sum VEAT and VIP for the reactions 4.2 & 4.3 was positive in ether, so it means these 
reactions are not favorable.  In this case NAS. + was not generated, and there are no chances 
of reaction 4.4 in ether. The same result was obtained in water during reaction 4.2. The 
Negative reaction energy was calculated in water during reaction 4.3 and produced NAS. + . 
Therefore NAS. + can accept electron from adenine and guanine. The above calculations show 
that there is no large difference between NA and its halogen substitutes. The result also 
suggests, all of them cannot damage DNA directly in oxygen free non polar solvents. But in 
oxygen free media polar solvent, the result shows the photo damage DNA by NA and its 
substitutes by the transfer of electron between NAS. + and DNA bases. 
In type II mechanism, NAS at T1 may react with ground state oxygen (3O2) by the transfer of 
energy to produce singlet oxygen (1O2) (Equation 4.5). 
)5.4.(........................................21)(23)( 01 ONASONAS sT +→+  
There is also a possibility that NAS at stat T1 may react with 3O2  by the transfer of electron 
to produce superoxide anion radical (O2.-) (Equation 4.6). 
)6.4.(.........................................2.23)( 1
−+ +→+ ONASONAS T  
It is found that the sum of VIPT1 for NAS and the calculated adiabatic electron affinity of 
oxygen AEAO2   in vacuum and ether are positive. It suggest that O2.- is not produced by the 
solvents path. It is also consider that there is an electron transfer reaction between NAS. + and 
3O2  (Equation 4.7).The generation of NAS. +  is from autoionization (Equation 4.3). 
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−
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The total reaction energy was positive for this reaction (7) in ether .Therefore the reaction is 
not permitted for NA. A similar analysis for NA showed that reaction is allowed because of 
negative reaction energy .The reaction was not permitted in all solvents for halogen 
substituted NA. It   may be consider that O2. –  was produced by the photo – irradiation of NA 
in water .When the O2.-   was produced , ROS such as H2O2 and .OH  can be produced by  
Fenton reaction or Haber –Weiss reaction. This will increase photosensitizing activity of NA 
very fast [Chen et al, 2006].
 
4.3. Theoretical Predictions  
The excitation energies, electron affinities and ionization potential of the four drugs 
(ofloxacin, enoxacin, norfloxacin and ciprofloxacin) were calculated by Gaussian03 and 
HyperChem software packages. The vertical excitation energies, electron affinities and 
ionization potential were calculated in solvent (water) by  B3LYP/6-31+G(d,p)//6-31G(d) 
scrf(pcm,solv=water)  and in vacuum by B3LYP/6-31+G(d,p)//6-31G(d) [(vacuum)] method 
as shown in figure 4.3&4.4.The calculations in vacuum were similar to 
HyperChem(Appendix A 5 & A 6).  
4.3.1. Calculations of Vertical Excitation Energies in Water  
The order (ciprofloxacin = norfloxacin < enoxacin > ofloxacin) in ionization energies of the 
four drugs is found from the theoretical calculations as shown in figure 4.3.The order 
(ciprofloxacin> norfloxacin > enoxacin > ofloxacin) is found in electron affinities.  The order 
in phototoxicity of these four drugs is ciprofloxacin < norfloxacin < enoxacin < ofloxacin 
(Kim Troensegaard Nielsen). The prediction of phototoxicity in drugs from electron affinity 
may be acceptable. As it clear shown in figure 4.3, ofloxacin has low electron affinity value 
than enoxacin. Therefore it may be more phototoxic than enoxacin. Similarly enoxacin is 
more phototoxic than norfloxacin and norfloxacin than ciprofloxacin.  
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Figure 4.3: Vertical excitation energies calculated by B3LYP/6-31+G(d,p)//6-31G(d) 
scrf(pcm,solv=water) 
4.3.2. Calculations of Vertical Excitation Energies in Vacuum 
The figure 4.5 shows the theoretical calculation of electron excitation energies, ionization 
energies and electron affinities of the four drugs (ofloxacin, enoxacin, norfloxacin and 
enoxacin). These calculations found similar to the calculations that were performed in 
HyperChem. From figure 4.4, it is difficult to predict phototoxicity of the drugs because of 
the irregular trends in ionization energy and electron affinity.  
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Figure 4.5: Vertical excitation energies calculated by B3LYP/6-31+G(d,p)//6-31G(d) 
[(vacuum)] 
 
 
 
 
 
 
 
 
 33 
 
Chapter 5 
5.1. Conclusion 
The presented optical spectroscopic investigations on fluoroquinolones derivatives 
(ofloxacin, enoxacin, norfloxacin and ciprofloxacin) have given good results on their 
electronic and vibrational structures. The observed infrared electronic spectra of the four 
drugs (ofloxacin, enoxacin, norfloxacin and ciprofloxacin) have given good agreement to 
theoretical predictions performed with Density Functional Theory, using the B3LYP 
functional and the 6-31G* basis set (B3LYP/6-31G*). However the difference in peak 
intensities of carboxylic acid O- H stretch is found in observed and theoretical spectra all 
drugs (ofloxacin, enoxacin, norfloxacin and ciprofloxacin). This difference in the peak 
intensities in both spectra may occur because of intra - molecular hydrogen bonding between 
the carboxyl hydroxy group and the keton carbonyl group in observed spectra.  
The UV- Vis absorption spectra of all the drugs (ofloxacin, enoxacin, norfloxacin and 
ciprofloxacin) were in recorded in organic solvent (methanol) and theoretical calculation 
predictions were performed  in Density Functional Theory, using the B3LYP functional and 
the 6-31G* basis set (B3LYP/6-31G*) – PCM methanol. The λmax of the drugs located at 300 
nm and 296 nm of ofloxacin, at 276 nm and 267 nm of enoxacin, at 283 nm and 280 nm of 
norfloxacin and at 283 nm and 282 of ciprofloxacin in both the observed spectra and 
theoretical predictions. This shows the good agreement between observed spectra and 
theoretical predictions of all the drugs (ofloxacin, enoxacin, norfloxacin and ciprofloxacin). 
The emission spectra of three drugs sample showed more than one emission peaks except 
ciprofloxacin. The emission peak of ciprofloxacin is located at 428. The different results of 
vertical excitation energies, electron affinities and ionization potential were calculated in 
solvent (water) by  B3LYP/6-31+G(d,p)//6-31G(d) scrf(pcm,solv=water)  and in vacuum by 
B3LYP/6-31+G(d,p)//6-31G(d) [(vacuum)] . 
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Appendix 
A 1: Absorption & Emission spectrum of Ofloxacin  
 
Figure 1: Absorption & Emission spectrum of ofloxacin in pure ethanol 
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A 2: Absorption & Emission spectrum of Enoxacin 
 
Figure 2: Absorption & Emission spectrum of enoxacin in pure ethanol 
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A 3: Absorption & Emission spectrum of Norfloxacin 
 
Figure3: Absorption & Emission spectrum of norfloxacin in pure ethanol 
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A 4: Absorption & Emission spectrum of Anthracene 
 
Figure 4: Absorption & Emission spectrum of anthracene in ethanol  
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A 5: Semi- Empirical Theoretical Calculations of Ionization Energy & Electron Affinity 
by HyperChem  
 
Figure 5: Theoretical calculations of Excitation energies by HyperChem  
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A 6: Semi- Empirical Theoretical Calculations of Ionization Energy & Electron Affinity 
by HyperChem  
 
 
Figure 6: Theoretical calculations of Excitation energies by HyperChem  
 
